BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,085 filers reported holding BAXTER INTL INC in Q1 2019. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,877,000 | -20.3% | 56,527 | +2.4% | 0.00% | -25.0% |
Q1 2024 | $2,354,000 | +17.8% | 55,189 | +6.6% | 0.00% | +33.3% |
Q4 2023 | $1,999,000 | -16.0% | 51,794 | -17.6% | 0.00% | -25.0% |
Q3 2023 | $2,379,000 | -23.5% | 62,887 | -7.7% | 0.00% | -33.3% |
Q2 2023 | $3,108,000 | +14.1% | 68,118 | +0.9% | 0.01% | 0.0% |
Q1 2023 | $2,723,000 | -59.5% | 67,478 | -48.8% | 0.01% | -60.0% |
Q4 2022 | $6,720,000 | -4.0% | 131,850 | +1.6% | 0.02% | -21.1% |
Q3 2022 | $7,003,000 | -17.4% | 129,800 | -1.8% | 0.02% | -13.6% |
Q2 2022 | $8,483,000 | -18.2% | 132,174 | -1.1% | 0.02% | -4.3% |
Q1 2022 | $10,366,000 | -7.5% | 133,676 | +2.3% | 0.02% | -8.0% |
Q4 2021 | $11,202,000 | +6.6% | 130,625 | +0.0% | 0.02% | -10.7% |
Q3 2021 | $10,506,000 | -0.5% | 130,621 | -0.5% | 0.03% | -9.7% |
Q2 2021 | $10,557,000 | +1.6% | 131,242 | +6.5% | 0.03% | -6.1% |
Q1 2021 | $10,392,000 | +9.1% | 123,277 | +3.9% | 0.03% | -17.5% |
Q4 2020 | $9,523,000 | -34.8% | 118,689 | -34.7% | 0.04% | -43.7% |
Q3 2020 | $14,610,000 | -3.3% | 181,757 | +3.5% | 0.07% | -13.4% |
Q2 2020 | $15,102,000 | +39.7% | 175,535 | +31.7% | 0.08% | +17.1% |
Q1 2020 | $10,813,000 | -2.6% | 133,275 | +4.6% | 0.07% | +16.7% |
Q3 2019 | $11,105,000 | +6.9% | 127,457 | +0.5% | 0.06% | -3.2% |
Q2 2019 | $10,387,000 | +13.6% | 126,793 | +12.7% | 0.06% | +1.6% |
Q1 2019 | $9,142,000 | +27.8% | 112,491 | +3.7% | 0.06% | +10.9% |
Q4 2018 | $7,154,000 | -21.3% | 108,502 | -8.1% | 0.06% | -16.7% |
Q3 2018 | $9,091,000 | +0.9% | 118,009 | -3.5% | 0.07% | -7.0% |
Q2 2018 | $9,013,000 | +11.3% | 122,247 | -1.6% | 0.07% | +4.4% |
Q1 2018 | $8,096,000 | +0.8% | 124,293 | -0.2% | 0.07% | +3.0% |
Q4 2017 | $8,028,000 | -7.8% | 124,498 | -10.1% | 0.07% | -10.8% |
Q3 2017 | $8,704,000 | +5.0% | 138,550 | +1.0% | 0.07% | 0.0% |
Q2 2017 | $8,292,000 | +28.9% | 137,148 | +10.4% | 0.07% | +19.4% |
Q1 2017 | $6,431,000 | +28.7% | 124,277 | +10.2% | 0.06% | +14.8% |
Q4 2016 | $4,996,000 | -8.1% | 112,754 | -0.9% | 0.05% | -14.3% |
Q3 2016 | $5,437,000 | +5.6% | 113,829 | +0.5% | 0.06% | -3.1% |
Q2 2016 | $5,150,000 | +44.1% | 113,285 | +30.0% | 0.06% | +441.7% |
Q1 2016 | $3,574,000 | -29.7% | 87,125 | -34.5% | 0.01% | -80.0% |
Q4 2015 | $5,081,000 | +30.6% | 132,952 | +12.4% | 0.06% | +15.4% |
Q3 2015 | $3,891,000 | -67.5% | 118,283 | -32.2% | 0.05% | -70.8% |
Q1 2015 | $11,957,000 | -13.9% | 174,553 | -7.9% | 0.18% | -16.4% |
Q4 2014 | $13,890,000 | -10.5% | 189,517 | -12.4% | 0.21% | -18.7% |
Q3 2014 | $15,523,000 | +4.3% | 216,284 | +5.0% | 0.26% | +1.6% |
Q2 2014 | $14,890,000 | +11.2% | 205,952 | +12.1% | 0.26% | -1.1% |
Q1 2014 | $13,391,000 | +15.6% | 183,761 | -0.5% | 0.26% | +9.7% |
Q4 2013 | $11,585,000 | +26.4% | 184,739 | +18.9% | 0.24% | +3.9% |
Q3 2013 | $9,165,000 | +23.0% | 155,418 | +44.4% | 0.23% | +12.8% |
Q2 2013 | $7,454,000 | – | 107,602 | – | 0.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
13D Management LLC | 200,318 | $14,791,000 | 3.77% |
ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |